Although several immune-related parameters, such as CD8+ T cell infiltration and PD-L1 expression, have been reported to predict the prognosis of patients with PAAD [5], immune prognostic models (IPMs) have not yet been developed for PAAD. The gene discussed is CD274; the disease is pancreatic adenocarcinoma.